ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,027,138 | +26.1% | 32,600 | 0.0% | 0.34% | +47.8% |
Q2 2023 | $12,705,198 | -23.4% | 32,600 | -26.7% | 0.23% | -29.2% |
Q1 2023 | $16,579,810 | +170.2% | 44,500 | +174.7% | 0.32% | +177.8% |
Q4 2022 | $6,137,046 | -93.6% | 16,200 | -94.0% | 0.12% | -93.4% |
Q3 2022 | $95,218,000 | +29.5% | 269,700 | +39.0% | 1.77% | +32.7% |
Q2 2022 | $73,503,000 | +37.3% | 194,000 | +14.3% | 1.33% | +53.5% |
Q1 2022 | $53,540,000 | +1321.7% | 169,800 | +493.9% | 0.87% | +1277.8% |
Q1 2020 | $3,766,000 | -90.8% | 28,591 | -88.8% | 0.06% | -89.3% |
Q4 2019 | $41,141,000 | +16.3% | 256,300 | -17.4% | 0.59% | -12.5% |
Q3 2019 | $35,373,000 | -19.5% | 310,400 | 0.0% | 0.67% | -1.5% |
Q2 2019 | $43,946,000 | -2.6% | 310,400 | -14.1% | 0.68% | -2.4% |
Q1 2019 | $45,105,000 | -27.5% | 361,300 | -44.2% | 0.70% | -39.3% |
Q4 2018 | $62,215,000 | +14.1% | 647,600 | -9.9% | 1.15% | +75.0% |
Q3 2018 | $54,514,000 | +9.8% | 718,800 | +19.9% | 0.66% | +11.0% |
Q2 2018 | $49,658,000 | +23.5% | 599,300 | +19.9% | 0.59% | +18.6% |
Q1 2018 | $40,220,000 | +27.4% | 500,000 | 0.0% | 0.50% | +25.1% |
Q4 2017 | $31,570,000 | +179.3% | 500,000 | 0.0% | 0.40% | +269.4% |
Q3 2017 | $11,305,000 | +6.6% | 500,000 | 0.0% | 0.11% | -2.7% |
Q2 2017 | $10,605,000 | – | 500,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |